| 臺大學術典藏 |
2022-03-04T03:48:41Z |
Clinical and pathological data of 10 malignant pheochromocytomas: Long-term follow up in a single institute
|
Huang K.-H.; Chung S.-D.; Chen S.-C.; Chueh S.-C.; Pu Y.-S.; Lai M.-K.; WEI-CHOU LIN |
| 臺大學術典藏 |
2022-03-04T03:48:36Z |
Primary Mucinous Adenocarcinoma of Renal Pelvis with Carcinoembryonic Antigen Production
|
Ho C.-H.; WEI-CHOU LIN; Pu Y.-S.; Yu H.-J.; Huang C.-Y. |
| 臺大學術典藏 |
2022-03-04T03:48:35Z |
The Role of Lymphovascular Invasion in Predicting the Prognosis of Clinically Localized Upper Tract Urothelial Carcinoma (pT1-3cN0M0)
|
WEI-CHOU LIN; Hu F.-C.; Chung S.-D.; Chueh S.-C.; Pu Y.-S.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:31Z |
Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors
|
Ho C.-H.; Huang C.-Y.; WEI-CHOU LIN; Chueh S.-C.; Pu Y.-S.; Lai M.-K.; Yu H.-J.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:30Z |
Expression of Stathmin in Localized Upper Urinary Tract Urothelial Carcinoma: Correlations With Prognosis
|
WEI-CHOU LIN; Chen S.-C.; Hu F.-C.; Chueh S.-C.; Pu Y.-S.; Yu H.-J.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:28Z |
An Unusual Presentation of Prostate Adenocarcinoma Metastatic to the Oral Cavity
|
Weng W.-C.; WEI-CHOU LIN; Pu Y.-S.; Yu H.-J.; Huang C.-Y. |
| 臺大學術典藏 |
2022-03-04T03:48:22Z |
2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells
|
Kuo K.-L.; WEI-CHOU LIN; Ho I.-L.; Chang H.-C.; Lee P.-Y.; Chung Y.-T.; Hsieh J.-T.; Pu Y.-S.; Shi C.-S.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:21Z |
Celecoxib-induced cytotoxic effect is potentiated by inhibition of autophagy in human urothelial carcinoma cells
|
Huang K.-H.; Kuo K.-L.; Ho I.-L.; Chang H.-C.; Chuang Y.-T.; WEI-CHOU LIN; Lee P.-Y.; Chang S.-C.; Chiang C.-K.; Pu Y.-S.; Chou C.-T.; Hsu C.-H.; Liu S.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:19Z |
Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma
|
Hu C.-Y.; Tsai Y.-C.; Wang S.-M.; Huang C.-Y.; Tai H.-C.; Chen C.-H.; Pu Y.-S.; WEI-CHOU LIN; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:18Z |
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
|
Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; WEI-CHOU LIN; Tsai Y.-C.; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; Pu Y.-S.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:18Z |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
WEI-CHOU LIN; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C.; Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; Liu S.-H.; Jeng Y.-M.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:16Z |
MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma
|
Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; WEI-CHOU LIN; Tsai Y.-C.; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:15Z |
Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience
|
Lien C.-C.; Liu K.-L.; Chow P.-M.; WEI-CHOU LIN; Tai H.-C.; Huang C.-Y.; Wang S.-M.; Huang K.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2022-03-04T03:48:14Z |
Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience
|
Lien C.-C.; Liu K.-L.; Chou P.-M.; WEI-CHOU LIN; Tai H.-C.; Huang C.-Y.; Wang S.-M.; Huang K.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2022-01-25T05:10:35Z |
Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7
|
Hsu Y.-H.; Lin W.-L.; Hou Y.-T.; Pu Y.-S.; Shun C.-T.; CHI-LING CHEN; Wu Y.-Y.; Chen J.-Y.; Chen T.-H.; Jou T.-S. |
| 臺大學術典藏 |
2022-01-17T08:00:28Z |
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
|
Chen C.-H.; Dickman K.G.; Huang C.-Y.; Moriya M.; Shun C.-T.; Tai H.-C.; Huang K.-H.; Wang S.-M.; YUAN-JU LEE; Grollman A.P.; Pu Y.-S. |
| 臺大學術典藏 |
2022-01-17T08:00:26Z |
Metallic ureteral stents in malignant ureteral obstruction: Clinical factors predicting stent failure
|
Chow P.-M.; Hsu J.-S.; Huang C.-Y.; Wang S.-M.; YUAN-JU LEE; Huang K.-H.; Yu H.-J.; Pu Y.-S.; Liang P.-C. |
| 臺大學術典藏 |
2022-01-17T08:00:25Z |
Paragangliomas of the urinary bladder: A report of 6 cases and review of the literature
|
Chang Y.-K.; Chiang I.-N.; Chen C.-H.; Wang S.-M.; YUAN-JU LEE; Pu Y.-S.; Huang C.-Y. |
| 臺大學術典藏 |
2022-01-17T08:00:25Z |
Malignant ureteral obstruction: Functional duration of metallic versus polymeric ureteral stents
|
Chow P.-M.; Chiang I.-N.; Chen C.-Y.; Huang K.-H.; Hsu J.-S.; Wang S.-M.; YUAN-JU LEE; Yu H.-J.; Pu Y.-S.; Huang C.-Y. |
| 臺大學術典藏 |
2022-01-17T08:00:24Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; YUAN-JU LEE; Chow P.-M.; Hung S.-C.; Huang C.-Y. |
| 臺大學術典藏 |
2022-01-17T08:00:24Z |
Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma
|
Chen C.-H.; Dickman K.G.; Huang C.-Y.; Shun C.-T.; Tai H.-C.; Huang K.-H.; Wang S.-M.; YUAN-JU LEE; Grollman A.P.; Pu Y.-S. |
| 臺大學術典藏 |
2022-01-17T08:00:22Z |
Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
|
Cheng Y.-T.; Huang C.-Y.; Chen C.-H.; Chiu S.-T.; Hong J.-H.; Pu Y.-S.; Liu S.-P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; YUAN-JU LEE; Chow P.-M.; Chiang I.-N.; Hung S.-C.; Chiang C.-H. |
| 臺大學術典藏 |
2021-11-30T04:54:06Z |
Clinical outcomes in patients undergoing laparoscopic adrenalectomy for unilateral aldosterone producing adenoma: Partial versus total adrenalectomy
|
Chen S.-F.; Chueh S.-C.; Wang S.-M.; VIN-CENT WU; Pu Y.-S.; Wu K.-D.; Huang K.-H. |
| 臺大學術典藏 |
2021-11-18T04:58:19Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L; Hsu C.-H; Lin J.-K; Hsu M.-M; Ho Y.-F; She T.-S; JENG-YUH KO; Lin J.-T; Lin B.-R; Wu M.-S; Yu H.-S; Jee S.-H; Chen G.-S; Chen T.-M; Chen C.-A; Lai M.-K; Pu Y.-S; Pan M.-H; Wang Y.-J; Tsai C.-C; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-11-15T07:48:43Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L; Hsu C.-H; Lin J.-K; Hsu M.-M; Ho Y.-F; She T.-S; JENG-YUH KO; Lin J.-T; Lin B.-R; Wu M.-S; Yu H.-S; Jee S.-H; Chen G.-S; Chen T.-M; Chen C.-A; Lai M.-K; Pu Y.-S; Pan M.-H; Wang Y.-J; Tsai C.-C; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-10-14T02:46:24Z |
Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines
|
Hour T.-C.; Chen J.; CHAO-YUAN HUANG; Guan J.-Y.; Lu S.-H.; Hsieh C.-Y.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:23Z |
Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells
|
Pu Y.-S.; Chen J.; CHAO-YUAN HUANG; Guan J.-Y.; Lu S.-H.; Hour T.-C. |
| 臺大學術典藏 |
2021-10-14T02:46:22Z |
Effect of percent free prostate-specific antigen measurement on improving the specificity of serum prostate-specific antigen testing in Taiwanese patients
|
Liao C.-H.; Liu S.-P.; Pu Y.-S.; CHAO-YUAN HUANG; Yu H.-J.; Chen J. |
| 臺大學術典藏 |
2021-10-14T02:46:21Z |
Cytotoxicity of arsenic trioxide to transitional carcinoma cells
|
Pu Y.-S.; Hour T.-C.; Chen J.; CHAO-YUAN HUANG; Guan J.-Y.; Lu S.-H. |
| 臺大學術典藏 |
2021-10-14T02:46:21Z |
Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/CIP1 and C/EBPβ expressions and suppressing NF-κB activation
|
Hour T.-C.; Chen J.; CHAO-YUAN HUANG; Guan J.-Y.; Lu S.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:20Z |
Arsenic trioxide as a novel anticancer agent against human transitional carcinoma - Characterizing its apoptotic pathway
|
Pu Y.-S.; Hour T.-C.; Chen J.; CHAO-YUAN HUANG; Guan J.-Y.; Lu S.-H. |
| 臺大學術典藏 |
2021-10-14T02:46:20Z |
Changing trends of prostate cancer in Asia
|
Pu Y.-S.; Chiang H.-S.; Lin C.-C.; CHAO-YUAN HUANG; Huang K.-H.; Chen J. |
| 臺大學術典藏 |
2021-10-14T02:46:19Z |
Primary amyloidosis of the urinary bladder
|
CHAO-YUAN HUANG; Shun C.-T.; Huang K.-H.; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:19Z |
Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide
|
Hour T.-C.; CHAO-YUAN HUANG; Lin C.-C.; Chen J.; Guan J.-Y.; Lee J.-M.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:18Z |
Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells
|
Pu Y.-S.; Hsieh M.-W.; Wang C.-W.; Liu G.-Y.; CHAO-YUAN HUANG; Lin C.-C.; Guan J.-Y.; Lin S.-R.; Hour T.-C. |
| 臺大學術典藏 |
2021-10-14T02:46:18Z |
Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity
|
Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:18Z |
Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer
|
Hour T.-C.; Pu Y.-S.; Lin C.-C.; Huang S.-W.; Chen J.; Chiu A.W.; Chen C.-J.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2021-10-14T02:46:17Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Cheng A.-L.; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:17Z |
Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy
|
Huang S.-P.; CHAO-YUAN HUANG; Wu W.-J.; Pu Y.-S.; Chen J.; Chen Y.-Y.; Yu C.-C.; Wu T.T.; Wang J.-S.; Lee Y.-H.; Huang J.-K.; Huang C.-H.; Wu M.-T. |
| 臺大學術典藏 |
2021-10-14T02:46:17Z |
High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan
|
Huang P.-C.; CHAO-YUAN HUANG; Huang S.-W.; Lai M.-K.; Yu H.-J.; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:16Z |
Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: A retrospective study of 1875 cases in Taiwan
|
Chiang I.-N.; Chang S.-J.; Pu Y.-S.; Huang K.-H.; Yu H.-J.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2021-10-14T02:46:16Z |
Malignant epithelioid angiomyolipoma of the kidney.
|
Huang K.H.; CHAO-YUAN HUANG; Chung S.D.; Pu Y.S.; Shun C.T.; Chen J. |
| 臺大學術典藏 |
2021-10-14T02:46:15Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:15Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:15Z |
Long-Term Follow-up of Hand-Assisted Laparoscopic Radical Nephrectomy for Organ-Confined Renal Cell Carcinoma
|
Chung S.-D.; Huang K.-H.; Lai M.-K.; CHAO-YUAN HUANG; Pu Y.-S.; Yu H.-J.; Chueh S.-C. |
| 臺大學術典藏 |
2021-10-14T02:46:14Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.; Shun C.-T.; Huang K.-H.; CHAO-YUAN HUANG; Tsai Y.-C.; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:14Z |
Intermediate Follow-up of Hand-Assisted Retroperitoneoscopic Nephroureterectomy for Management of Upper Urinary Tract Urothelial Carcinoma: Comparison with Open Nephroureterectomy
|
Chung S.-D.; CHAO-YUAN HUANG; Chueh S.-C.; Pu Y.-S.; Lai M.-K.; Yu H.-J.; Huang K.-H. |
| 臺大學術典藏 |
2021-10-14T02:46:14Z |
Long-term outcome of hand-assisted laparoscopic radical nephroureterectomy for upper-tract urothelial carcinoma: Comparison with open surgery
|
Chung S.-D.; Chueh S.-C.; Lai M.-K.; CHAO-YUAN HUANG; Pu Y.-S.; Yu H.-J.; Huang K.-H. |
| 臺大學術典藏 |
2021-10-14T02:46:14Z |
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial
|
Lin C.-C.; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; CHAO-YUAN HUANG; Huang K.-H.; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:13Z |
Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post-radical prostatectomy
|
Huang S.-P.; CHAO-YUAN HUANG; Wang J.-S.; Liu C.-C.; Pu Y.-S.; Yu H.-J.; Yu C.-C.; Wu T.T.; Huang C.-H.; Wu W.-J.; Chou Y.-H.; Wu M.-T. |
